South Korea Myopia and Presbyopia Treatment Market: Insights, Trends, and Growth Projections (2025-2034)

The South Korea myopia and presbyopia treatment market is experiencing significant growth, fueled by factors such as an aging population, increasing rates of diabetes, and prolonged screen time. With a projected compound annual growth rate (CAGR) of 7.0% between 2025 and 2034, this market is poised for further expansion. As the prevalence of eye-related ailments increases, demand for myopia and presbyopia treatments continues to rise. This article explores the market size, trends, growth drivers, and challenges, along with the latest developments shaping this industry in South Korea.

Market Overview

The South Korea myopia and presbyopia treatment market is critical to addressing the vision care needs of a growing aging population and a tech-savvy younger generation. Myopia (nearsightedness) and presbyopia (age-related farsightedness) are prevalent conditions that affect millions, making effective treatments essential. With advances in medical technology, innovative treatment options are emerging, including prescription lenses, contact lenses, intraocular lenses, refractive surgery, and drugs. South Korea’s advanced healthcare infrastructure and high-quality medical services make it a key player in the Asia-Pacific eye care market.

Market Size and Share

As of 2024, the South Korea myopia and presbyopia treatment market is witnessing significant demand, largely driven by demographic changes and the increasing adoption of digital devices. The market is estimated to grow at a robust CAGR of 7.0% from 2025 to 2034. By 2034, the market value is expected to reach an estimated USD 2.5 billion, up from its 2024 value of around USD 1.5 billion. This growth trajectory reflects the increasing prevalence of vision impairments, the country’s focus on improving eye care, and rising public awareness about vision health.

Get a free sample request: https://www.expertmarketresearch.com/reports/south-korea-myopia-and-presbyopia-treatment-market/requestsample

Market Trends

Aging Population and Increased Incidence of Presbyopia
The aging population in South Korea is a significant factor driving the market’s growth. As people live longer, presbyopia—a condition that affects individuals over the age of 40—has become more common. The increasing number of elderly people requiring eye care services contributes to the demand for presbyopia treatments, particularly intraocular lenses and refractive surgery.
Technological Advancements in Myopia Treatment
Technological innovations in myopia treatment, such as myopia control lenses and advanced refractive surgery techniques like LASIK and SMILE, are reshaping the market. These technologies offer precise, less invasive, and faster solutions to correct myopia. As myopia rates continue to rise, especially among the younger population, these innovative treatments are expected to drive market growth significantly.
Impact of Increased Screen Time
Increased screen time from smartphones, computers, and other digital devices has been linked to a rise in myopia cases, especially among children and young adults. As digital device usage becomes more integral to daily life, the demand for effective treatment options to address myopia is increasing. Companies are developing new, specialized lenses that help mitigate the effects of prolonged screen exposure, which is expected to further boost the market.
Shift Towards Preventive and Personalized Eye Care
Consumers are increasingly seeking personalized and preventive eye care solutions to manage myopia and presbyopia. Customized lenses and treatments tailored to individual needs are gaining popularity, especially as awareness of eye health improves. This trend is being supported by advancements in diagnostic technologies that help practitioners assess eye conditions more accurately and provide personalized treatment plans.

Market Analysis

Disease Type Segmentation
The South Korea myopia and presbyopia treatment market is divided into myopia and presbyopia segments. Myopia, or nearsightedness, is more prevalent among younger populations, with rising cases of childhood myopia due to digital device usage. Presbyopia, on the other hand, affects the aging population and is driving demand for intraocular lenses and other age-related treatments. Both segments are poised for growth, but presbyopia is expected to see the highest demand due to the aging demographic.
Treatment Type Segmentation
Treatment options in the South Korea market include prescription lenses, contact lenses, intraocular lenses, refractive surgery, and drugs. Prescription lenses and contact lenses dominate the market, as they are the most commonly used treatments for myopia and presbyopia. Refractive surgeries such as LASIK and SMILE are also gaining popularity, especially among those seeking permanent solutions. Intraocular lenses are increasingly used to treat presbyopia in elderly patients, contributing to the growth of this treatment segment.
Technological Advancements in Myopia Treatments
The myopia treatment segment in South Korea is benefiting from technological advancements such as myopia control contact lenses and digital eye tracking devices. These innovations aim to slow the progression of myopia, particularly in children. As myopia becomes more prevalent, these advanced technologies are expected to play a crucial role in managing the condition, thus boosting market growth in the coming years.
Regional Insights and Market Potential
South Korea is a technologically advanced nation with a robust healthcare infrastructure, making it a key market for eye care products and treatments. With a high level of awareness about eye health and excellent access to advanced treatments, South Korea is likely to remain a significant player in the global myopia and presbyopia treatment market. Urban centers such as Seoul are expected to witness the highest demand due to a concentration of healthcare facilities and a larger aging population.

Market Growth

Several factors contribute to the expected market growth in South Korea, including the rising prevalence of myopia and presbyopia, technological advancements, and increased screen time. The aging population is particularly important, as it requires treatments for presbyopia, which is expected to drive demand for intraocular lenses and refractive surgery. Additionally, the growing awareness of the importance of eye health and innovations in myopia treatments are expected to create new opportunities for market expansion. As digital device usage continues to rise, myopia treatments will remain in high demand.

Recent Developments Challenges

Innovation in Myopia Control Products
Recently, companies in South Korea have introduced innovative myopia control products, including specialized lenses and eye exercises aimed at slowing the progression of myopia. These products are designed to address the growing concern of childhood myopia, driven by excessive screen time. Such innovations are expected to drive the demand for myopia treatments, especially among younger populations.
Regulatory Changes in Eye Care
The regulatory framework for the approval of eye care products in South Korea has become more streamlined, ensuring quicker access to innovative treatments. As more products receive regulatory approval, manufacturers are expanding their portfolios to offer a wide range of treatments for myopia and presbyopia, thus fostering market growth. The government’s focus on improving healthcare accessibility is also likely to support the expansion of this market.
Technological Advancements in Refractive Surgery
Refractive surgery technologies, including LASIK and SMILE, have undergone significant advancements, offering more precise and safer outcomes for patients with myopia and presbyopia. These innovations have led to an increase in demand for surgical treatments, especially among those seeking long-term solutions to vision problems. The popularity of these procedures is expected to rise, further fueling market growth.
Challenges in Widespread Adoption
Despite technological advancements, widespread adoption of certain treatments such as refractive surgeries remains a challenge due to their high cost and the potential for side effects. Many individuals still prefer traditional lenses and glasses as more affordable and accessible options. Additionally, there is a need for greater public awareness of available treatments, which will be key to overcoming barriers to adoption in the market.

Key Players

Johnson Johnson Vision
Johnson Johnson Vision is a global leader in vision care, offering a wide range of products for treating myopia and presbyopia. The company’s portfolio includes contact lenses, intraocular lenses, and surgical instruments for refractive surgery. With its strong RD capabilities and innovative solutions, Johnson Johnson Vision is well-positioned to meet the growing demand for eye care products in South Korea.
T Korea Solution Co., Ltd.
T Korea Solution is a South Korean company specializing in advanced eye care technologies, including solutions for myopia and presbyopia. The company’s product offerings include both corrective lenses and cutting-edge myopia control technologies. T Korea Solution’s strong focus on innovation and patient-centric solutions makes it a key player in the South Korean market.
Alcon Inc.
Alcon, a global leader in eye care, offers a comprehensive range of products for myopia and presbyopia treatment, including contact lenses, intraocular lenses, and refractive surgery solutions. Alcon is known for its high-quality products and advanced technologies, which have established it as a trusted brand in the South Korean eye care market.
AbbVie
AbbVie is a pharmaceutical company that plays a significant role in the eye care market in South Korea. Known for its innovative treatments for presbyopia, AbbVie has developed novel drugs and surgical solutions to address the condition. Its commitment to research and development has positioned AbbVie as an important player in the market.

Other Companies
HOYA Corporation and several other companies are also contributing to the growth of the South Korean myopia and presbyopia treatment market with their range of corrective lenses and eye care products.

FAQs

Q: What is the difference between myopia and presbyopia?
Myopia, or nearsightedness, is a condition where distant objects appear blurry, typically caused by an elongated eyeball or steep cornea. Presbyopia, on the other hand, is an age-related condition where the eye loses its ability to focus on close objects due to the stiffening of the eye's lens.

Q: How are myopia and presbyopia treated?
Myopia is commonly treated with prescription glasses, contact lenses, or refractive surgery. Presbyopia is typically treated with reading glasses, intraocular lenses, or refractive surgery. In some cases, medications or specialized contact lenses may be prescribed.

Q: What factors are driving the growth of the South Korean myopia and presbyopia treatment market?
The growth of this market is driven by factors such as the aging population, increased screen time, technological advancements in treatment options, and the rising prevalence of myopia and pres

byopia.

Q: What challenges does the South Korean market face?
Challenges include high treatment costs, particularly for refractive surgeries, and the need for greater public awareness of available treatment options. Additionally, while surgical treatments are becoming more popular, traditional methods like glasses and lenses still dominate the market.